Brief: Geovax Labs Presents Results From A Clinical Study Of A Combinational HIV Therapy
27/02/2023 14:16
Feb 27 (Reuters) - GeoVax Labs Inc GOVX.O :
* PRESENTATION OF RESULTS FROM A CLINICAL STUDY OF A
COMBINATIONAL
HIV THERAPY THAT INCLUDED GEOVAX'S HIV VACCINE CANDIDATE, MVA62B
* DATA PRESENTED INDICATED VERY HIGH LEVELS OF
IMMUNOGENICITY OF
COMBINATIONAL THERAPY
Source text for Eikon: ID:nGNXbrPfXJ
Further company coverage: GOVX.O
((Reuters.Briefs@thomsonreuters.com))